PBM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Psyence Biomedical Ltd (PBM) is not a good buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock exhibits weak financial performance, lacks positive catalysts, and has no significant trading signals or institutional interest. Additionally, the technical indicators suggest bearish trends despite the pre-market price increase.
The MACD is positive and expanding, indicating short-term bullish momentum. However, the RSI indicates the stock is oversold, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 2.273), with resistance levels significantly higher, suggesting limited upside potential in the short term.
NULL identified. The pre-market price increase of 8.19% lacks supporting news or trading signals.
The company recently settled a $1.5 million shareholder claim, which could indicate underlying legal or operational issues. Financial performance is severely deteriorating, with a significant drop in net income (-632.44% YoY) and EPS (-142.23% YoY).
In 2026/Q2, revenue remained at 0 with no growth. Net income dropped significantly to -753,254 (-632.44% YoY), and EPS fell to -3.18 (-142.23% YoY). Gross margin remains at 0, indicating no profitability.
No analyst rating or price target data available.
